• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Miscellaneous

You have free access to this content

UNIT 7.3 Overview of Drug Product Development

  1. Padma Narayan

Published Online: 1 DEC 2011

DOI: 10.1002/0471141755.ph0703s55

Current Protocols in Pharmacology

Current Protocols in Pharmacology

How to Cite

Narayan, P. 2011. Overview of Drug Product Development. Current Protocols in Pharmacology. 55:7.3.1–7.3.29.

Author Information

  1. The Dow Chemical Company, Engineering Sciences, Solids Processing, Midland, Michigan

Publication History

  1. Published Online: 1 DEC 2011
  2. Published Print: DEC 2011

The process for developing drug delivery systems has evolved over the past two decades with more scientific rigor, involving a collaboration of various fields, i.e., biology, chemistry, engineering, and pharmaceutics. Drug products, also commonly known in the pharmaceutical industry as formulations or “dosage forms,” are used for administering the active pharmaceutical ingredient (API) for purposes of assessing safety in preclinical models, early- to late-phase human clinical trials, and for routine clinical/commercial use. This overview discusses approaches for creating small-molecule API dosage forms, from preformulation to commercial manufacturing. Curr. Protoc. Pharmacol. 55:7.3.1-7.3.29. © 2011 by John Wiley & Sons, Inc.

Keywords: drug product development; pharmaceutical formulations; pharmaceutical development